Immediate Impact
52 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Multiple myeloma
2024 Standout
Works of Stefania Oliva being referenced
Poor Prognosis of Multiple Myeloma Predicted By High Levels of Circulating Plasma Cells Is Independent from Other High-Risk Features but Is Modulated By the Achievement of Minimal Residual Disease Negativity
2020
Validation of SKY92 high and low risk prognostication in a retrospective, multinational cohort of 155 non-trial multiple myeloma patients
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Stefania Oliva | 120 | 141 | 84 | 33 | 219 | |
| Wei Zeng | 50 | 128 | 30 | 32 | 292 | |
| Hua Yan | 70 | 157 | 46 | 21 | 234 | |
| Yalda Hekmatshoar | 46 | 158 | 43 | 22 | 255 | |
| Min Xu | 74 | 201 | 30 | 21 | 298 | |
| Yaozhu Pan | 42 | 116 | 27 | 22 | 214 | |
| İşıl Albeniz | 24 | 115 | 46 | 29 | 282 | |
| Yasumasa Sugita | 43 | 93 | 34 | 27 | 281 | |
| Jana Škerlová | 12 | 211 | 49 | 27 | 294 | |
| Eric D. Eisenmann | 48 | 78 | 78 | 28 | 256 | |
| Tingbo Liu | 68 | 132 | 82 | 45 | 296 |
All Works
Login with ORCID to disown or claim papers
Loading papers...